Mapping Waste in a Clinical Supply Chain

Abstract

This thesis examines the generation and management of waste in the clinical supply chain of AstraZeneca, with a specific focus on the sustainability challenges inherent in clinical trials. Despite the growing emphasis on sustainability in healthcare and biotechnology, the clinical supply chain has received less attention compared to the commercial supply chain. This research identifies key areas within clinical trials that contribute to unsustainability and proposes methods to mitigate waste and enhance ecological and economic sustainability. The study utilizes a mixed-methods approach, combining a literature review with qualitative interviews conducted with employees directly involved in AstraZeneca's clinical supply chain. This methodological approach helps to map out the waste production points within the study supply chain and identify factors contributing to waste. The findings indicate that significant waste occurs due to factors such as forecasting inaccuracies, communication challenges, and inefficiencies in labelling and packaging processes. By providing a detailed analysis of waste generation in a crucial but understudied area of pharmaceutical operations the thesis will contribute to and expand the field. It suggests that improving forecasting accuracy, enhancing information channels, and adopting innovative labelling solutions like digital labelling could significantly reduce waste. This research supports the development of more sustainable practices within the pharmaceutical industry, promoting not only environmental benefits but also operational efficiencies.